Case report reveals effective treatment of teprotumumab-induced encephalopathy, suggesting importance of early recognition.
We present a case of teprotumumab-induced encephalopathy responsive to plasmapheresis, further supporting the need for early recognition of this potential adverse effect.
No takes yet. Share an insight, caveat, or question.
Siddiqui et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: